The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat

Inflammation

Volumn 22, Issue 5, 1998, Pages 509-519

  Gilroy, D W ^a   Tomlinson, A ^a   Greenslade, K ^a   Seed, M P ^a   Willoughby, D A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GLYCOSAMINOGLYCAN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE EROSION; BONE MASS; CARTILAGE DEGENERATION; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; INFLAMMATORY CELL; MALE; MONARTHRITIS; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN EXPRESSION; RAT; SYNOVIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, INFECTIOUS; BONE AND BONES; CARTILAGE, ARTICULAR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; ISOENZYMES; MALE; MYCOBACTERIUM TUBERCULOSIS; NITROBENZENES; PIROXICAM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; SULFONAMIDES;

ANIMALIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; RATTUS NORVEGICUS;

EID: 0031793082     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022350111213     Document Type: Article

References (31)

1. HENDERSON, B. and E. R. PETTIPHER. 1985. The synovial lining cell: biology and pathobiology. Semin. Arthritis Rheum. 15:1-32.
2. XIE, W. L., J. G. CHIPMAM, D. L. ROBERTSON, R. L. ERIKSON, and D. L. SIMMONS. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 88:2692-2696.
3. KUJUBU, D. A., B. S. FLETCHER, B. C. VARNUM, R. W. LIM, and H. R. HERSCHMAN. 1991. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:12866-12872.
4. VANE, J. R., J. A. MITCHELL, I. APPLETON, A. TOMLINSON, D. BISHOP-BAILEY, J. CROXTALL, and D. A. WILLOUGHBY. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U.S.A. 91:2046-2050.
5. TOMLINSON, A., I. APPLETON, A. R. MOORE, D. W. GILROY, D. WILLIS, J. A. MITCHELL, and D. A. WILLOUGHBY. 1994. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 113:693-698.
6. ANDERSON, G. D., S. D. HAUSER, K. L. MCGARITY, M. E. BREMER, P. C. ISAKSON, and S. A. GREGORY. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97:2672-2679.
7. CROFFORD, L. J., R. L. WILDER, A. P. RISTIMAKI, H. SANO, E. F. REMMERS, H. R. EPPS, and T. HLA. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J. Clin. Invest. 93:1095-1101.
8. VANE, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:232-235.
9. PETTIPHER, E. R., B. HENDERSON, J. C. EDWARDS, and G. A. HIGGS. 1989. Effects of indomethacin on swelling, lymphocyte influx and cartilage proteoglycan depletion in experimental arthritis. Ann. Rheum. Dis. 48:623-627.
10. BRANDT, K. D. 1987. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am. J. Med. 83:29-34.
11. BOTTOMLEY, K. M. K., R. J. GRIFFITHS, T. J. RISING, and A. STEWARD. 1986. A modified mouse air pouch model for evaluating the effects of compounds on granuloma-induced cartilage degradation. British Journal of Pharmacology 93:627-635.
12. BRANDT, K. D. 1987. Nonsteroidal antiinflammatory drugs and articular cartilage. J. Rheumatol. 14:132-133.
13. BULSTRA, S. K., R. KUIJER, W. A. BUURMAN, E. TERWINDT-ROUWENHORST, P. J. GUELEN, and A. J. VAN DER LINDEN. 1992. The effect of piroxicam on the metabolism of isolated human chondrocytes. Clin. Orthop. 277:289-296.
14. MITCHELL, J. A., P. AKARASEREENONT, C. THIEMERMANN, C. R. J. FLOWER, and J. R. VANE. 1993. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90:11693-11697.
15. BATEMAN, D. N. 1994. NSAIDs: time to re-evaluate gut toxicity [comment]. Lancet 343:1051-1052.
16. SEED, M. P., F. L. PARKER, S. JOHNS, A. P. CURNOCK, A. BOWDEN, and C. R. GARDNER. 1991. Mycobacterium tuberculosis - induced monoarticular arthritis in the rat, a new in vivo model for the assessment of anti-rheumatic drugs. Clinical Rheumatology 10:461-462.
17. FUTAKI, N., K. YOSHIKAWA, Y. HAMASAKA, I. ARAI, S. HIGUCHI, H. IIZUKA, and S. OTOMO. 1993. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24:105-110.
18. GROSSMAN, C. J., J. WISEMAN, F. S. LUCAS, M. A. TREVETHICK, and P. J. BIRCH. 1995. Inhibition of inducible and constitutive cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and COX 2 inhibitors. Inflammation Research 44:253-257.
19. SEED, M. P., A. R. BOWDEN, F. P. PARKER, S. JOHNS, A. CURNOCK, and C. R. GARDNER. 1995. Chondroneutral and chondrotoxic diversity of nonsteroidal antiinflammatory drugs. Br. J. Rheum. 34:15.
20. SEED, M. P., P. H. HAMBLETON, A. R. BOWDEN, S. C. J. CLEMENTS-JEWERY, and C. R. GARDNER. 1993. Rapid quantitation of joint destruction in irritant monoarticular arthritis induced by heat killed Mycobacterium tuberculosis. European Journal of Rheumatology and Inflammation 13:27-33.
21. FARNDALE, R. W., D. J. BUTTLE, and A. J. BARRET. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethyl blue. Biochem. Biophys. Acta. 883:173-177.
22. MASFERRER, J. L., B. S. ZWEIFEL, P. T. MANNING, P. T. HAUSER, K. M. LEAHY, W. G. SMITH, P. C. ISAKSON, and K. SEIBERT. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and non-ulcerogenic. Proc. Natl. Acad. Sci. U.S.A. 91:3228-3232.
23. HARADA, Y., K. HATANAKA, M. KAWAMURA, M. SAITO, M. OGINO, M. MAJIMA, T. OHNO, K. OGINO, K. YAMAMOTO, Y. TAKETANI, S. YAMAMOTO, and M. KATORI. 1996. Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. Prostaglandins 51:19-33.
24. MAGNI, E. 1993. The effect of nimesulide on prostanoid formation. Drugs 46:10-14.
25. DINGLE, J. T., and M. J. SHIELD. 1990. The interactions of cytokines, NSAIDs and prostaglandins in cartilage destruction and repair. Advances in Prostaglandin, Thromboxane and Leukotriene Research 21:955-966.
26. NEWMAN, N. M. and R. S. LING. 1985. Acetabular bone destruction related to nonsteroidal anti-inflammatory drugs. Lancet 2:11-14.
27. MIZEL, S. B., J. M. DAYER, S. M. KRANE, and S. E. MERGENHAGEN. 1981. Stimulation of rheumatoid cell collagenase and prostaglandin production by partially purified lymphocyte activation factor (interleukin-1). Proc. Natl. Acad. Sci. U.S.A. 78:2474-2477.
28. KUNKEL, S. L., S. W. CHEMSUE, and S. H. PHAN. 1986. Prostaglandins as endogenous mediators of interleukin production. J. Immunol. 136:186-192.
29. MERTZ, P. M., D. L. DEWITT, W. G. STETLER-STEVENSON, and L. M. WAHL. 1994. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of protaglandin-dependant matrix metalloproteinase production. J. Biol. Chem. 269:21322-21329.
30. ADOLPHSON, P., H. ABBASZADEGAN, U. JONSSON, N. DALEN, H. E. SJOBERG, and S. KALEN. 1993. No effects of piroxicam on osteopenia and recovery after Colles' fracture. A randomized, double-blind, placebo-controlled, prospective trial. Arch. Orthop. Trauma Surg. 112:127-130.
31. ADOLPHSON, P., U. JONSSON, and N. DALEN, N. 1991. Piroxicam-induced reduction in osteopenia after external fixation of rabbit tibia. Acta. Orthop. Scand. 62:363-366.